Kevin T Conroy Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kevin T Conroy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kevin T Conroy. Kevin T Conroy is President & CEO in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and President and CEO in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and VP, General Counsel in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and President & CEO in EXACT SCIENCES CORP ($EXAS) and President and CEO in EXACT SCIENCES CORP ($EXAS) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in Epizyme, Inc. ($EPZM) and Director in ARYA SCIENCES ACQUISITION CORP. ($ARYA).
Latest Insider Trading Transactions of Kevin T Conroy
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADPT, ARYA, EPZM, EXAS, TWTI
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 131.09 | 19,240 | 2,522,172 | 757,496 | 776.7 K to 757.5 K (-2.48 %) |
| May 05 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Grant | A | 64.74 | 328 | 21,235 | 776,736 | 776.4 K to 776.7 K (+0.04 %) |
| May 05 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 131.09 | 19,240 | 2,522,172 | 757,496 | 776.7 K to 757.5 K (-2.48 %) |
| May 05 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Grant | A | 64.74 | 328 | 21,235 | 776,736 | 776.4 K to 776.7 K (+0.04 %) |
| Apr 01 2021 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 8.71 | 1,723 | 15,007 | 11,282 | 9.6 K to 11.3 K (+18.02 %) |
| Mar 03 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 20,575 | 0 | 20,575 | |
| Mar 03 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 138.42 | 9,796 | 1,355,962 | 799,163 | 809 K to 799.2 K (-1.21 %) |
| Mar 03 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 20,575 | 0 | 808,959 | 788.4 K to 809 K (+2.61 %) |
| Feb 25 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 34,325 | 0 | 0 | |
| Feb 25 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 136.30 | 16,420 | 2,238,046 | 810,365 | 826.8 K to 810.4 K (-1.99 %) |
| Feb 25 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 34,325 | 0 | 826,785 | 792.5 K to 826.8 K (+4.33 %) |
| Feb 18 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 31,132 | 0 | 93,398 | |
| Feb 18 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 142.66 | 15,825 | 2,257,595 | 792,460 | 808.3 K to 792.5 K (-1.96 %) |
| Feb 18 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 31,132 | 0 | 808,285 | 777.2 K to 808.3 K (+4.01 %) |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | Conroy Kevin T | Director | Option Exercise | A | 66.50 | 3,759 | 249,974 | 3,759 | |
| Feb 17 2021 | ADPT | Adaptive Biotechno ... | Conroy Kevin T | Director | Grant | A | 0.00 | 1,504 | 0 | 1,504 | 0 to 1.5 K |
| Feb 09 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 5.70 | 17,543 | 99,995 | 229,757 | |
| Feb 09 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 5.70 | 17,543 | 99,995 | 777,153 | 759.6 K to 777.2 K (+2.31 %) |
| Feb 03 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 138.07 | 30,344 | 4,189,596 | 759,610 | 790 K to 759.6 K (-3.84 %) |
| Feb 03 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Gift | G | 0.00 | 35,750 | 0 | 789,954 | 825.7 K to 790 K (-4.33 %) |
| Jan 07 2021 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 128.74 | 31,814 | 4,095,734 | 825,704 | 857.5 K to 825.7 K (-3.71 %) |
| Jan 05 2021 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 10.86 | 1,024 | 11,121 | 9,559 | 8.5 K to 9.6 K (+12.00 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 124.71 | 400 | 49,884 | 888,095 | 888.5 K to 888.1 K (-0.05 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 123.45 | 600 | 74,070 | 888,495 | 889.1 K to 888.5 K (-0.07 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 124.71 | 400 | 49,884 | 888,095 | 888.5 K to 888.1 K (-0.05 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 122.33 | 9,577 | 1,171,554 | 889,095 | 898.7 K to 889.1 K (-1.07 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 123.45 | 600 | 74,070 | 888,495 | 889.1 K to 888.5 K (-0.07 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 121.52 | 10,229 | 1,243,028 | 898,672 | 908.9 K to 898.7 K (-1.13 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 122.33 | 9,577 | 1,171,554 | 889,095 | 898.7 K to 889.1 K (-1.07 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 120.45 | 6,512 | 784,370 | 908,901 | 915.4 K to 908.9 K (-0.71 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 121.52 | 10,229 | 1,243,028 | 898,672 | 908.9 K to 898.7 K (-1.13 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 119.18 | 1,108 | 132,051 | 915,413 | 916.5 K to 915.4 K (-0.12 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 120.45 | 6,512 | 784,370 | 908,901 | 915.4 K to 908.9 K (-0.71 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 118.32 | 4,393 | 519,780 | 916,521 | 920.9 K to 916.5 K (-0.48 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 119.18 | 1,108 | 132,051 | 915,413 | 916.5 K to 915.4 K (-0.12 %) |
| Nov 03 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 118.32 | 4,393 | 519,780 | 916,521 | 920.9 K to 916.5 K (-0.48 %) |
| Oct 02 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 105.20 | 1,136 | 119,507 | 920,914 | 922.1 K to 920.9 K (-0.12 %) |
| Oct 02 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 104.70 | 5,200 | 544,440 | 922,050 | 927.3 K to 922.1 K (-0.56 %) |
| Oct 02 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 103.57 | 9,391 | 972,626 | 927,250 | 936.6 K to 927.3 K (-1.00 %) |
| Oct 02 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 102.86 | 11,698 | 1,203,256 | 936,641 | 948.3 K to 936.6 K (-1.23 %) |
| Oct 01 2020 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 11.93 | 933 | 11,131 | 8,535 | 7.6 K to 8.5 K (+12.27 %) |
| Sep 02 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 75.03 | 19,927 | 1,495,123 | 948,339 | 968.3 K to 948.3 K (-2.06 %) |
| Aug 04 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 95.00 | 198 | 18,810 | 968,266 | 968.5 K to 968.3 K (-0.02 %) |
| Aug 04 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 93.79 | 25,000 | 2,344,750 | 968,464 | 993.5 K to 968.5 K (-2.52 %) |
| Aug 04 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Grant | A | 42.44 | 501 | 21,262 | 993,464 | 993 K to 993.5 K (+0.05 %) |
| Jul 06 2020 | ARYA | ARYA SCIENCES ACQU ... | Conroy Kevin T | Director | Option Exercise | D | 0.00 | 30,000 | 0 | 0 | |
| Jul 01 2020 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 16.06 | 693 | 11,130 | 7,602 | 6.9 K to 7.6 K (+10.03 %) |
| Jun 02 2020 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
| Apr 02 2020 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 15.51 | 717 | 11,121 | 6,909 | 6.2 K to 6.9 K (+11.58 %) |
| Mar 02 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 20,575 | 0 | 41,150 | |
| Mar 02 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 80.17 | 9,750 | 781,658 | 992,963 | 1 M to 993 K (-0.97 %) |
| Mar 02 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 20,575 | 0 | 1,002,713 | 982.1 K to 1 M (+2.09 %) |
| Feb 26 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 34,325 | 0 | 34,325 | |
| Feb 26 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 85.11 | 18,115 | 1,541,768 | 966,676 | 984.8 K to 966.7 K (-1.84 %) |
| Feb 26 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 34,325 | 0 | 984,791 | 950.5 K to 984.8 K (+3.61 %) |
| Feb 18 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | A | 0.00 | 124,530 | 0 | 124,530 | |
| Feb 18 2020 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | A | 98.18 | 100,916 | 9,907,933 | 100,916 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | Conroy Kevin T | Director | Option Exercise | A | 31.71 | 8,888 | 281,838 | 8,888 | |
| Jan 03 2020 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 24.60 | 452 | 11,119 | 6,192 | 5.7 K to 6.2 K (+7.87 %) |
| Dec 18 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 23.38 | 4,277 | 99,996 | 66,723 | |
| Dec 18 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 13.96 | 7,163 | 99,995 | 102,837 | |
| Dec 18 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 23.38 | 4,277 | 99,996 | 950,466 | 946.2 K to 950.5 K (+0.45 %) |
| Dec 18 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 13.96 | 7,163 | 99,995 | 946,189 | 939 K to 946.2 K (+0.76 %) |
| Dec 18 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Grant | A | 42.44 | 500 | 21,220 | 939,026 | 938.5 K to 939 K (+0.05 %) |
| Jul 02 2019 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 12.55 | 887 | 11,132 | 4,662 | 3.8 K to 4.7 K (+23.50 %) |
| Jun 07 2019 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 | |
| Jun 07 2019 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 12.39 | 897 | 11,114 | 3,775 | 2.9 K to 3.8 K (+31.17 %) |
| Mar 12 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 24,400 | 0 | 0 | |
| Mar 12 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 87.21 | 11,227 | 979,129 | 938,526 | 949.8 K to 938.5 K (-1.18 %) |
| Mar 12 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 24,400 | 0 | 949,753 | 925.4 K to 949.8 K (+2.64 %) |
| Mar 01 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 93.20 | 10,014 | 933,345 | 925,353 | 935.4 K to 925.4 K (-1.07 %) |
| Feb 28 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 20,575 | 0 | 61,725 | |
| Feb 28 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | A | 0.00 | 37,248 | 0 | 37,248 | |
| Feb 28 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | A | 92.62 | 34,110 | 3,159,268 | 34,110 | |
| Feb 28 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 20,025 | 0 | 20,025 | |
| Feb 28 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 20,575 | 0 | 935,367 | 914.8 K to 935.4 K (+2.25 %) |
| Feb 28 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 95.07 | 9,169 | 871,734 | 914,792 | 924 K to 914.8 K (-0.99 %) |
| Feb 28 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 20,025 | 0 | 923,961 | 903.9 K to 924 K (+2.22 %) |
| Feb 26 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 34,325 | 0 | 68,650 | |
| Feb 26 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 90.55 | 16,400 | 1,485,036 | 903,936 | 920.3 K to 903.9 K (-1.78 %) |
| Feb 26 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 34,325 | 0 | 920,336 | 886 K to 920.3 K (+3.87 %) |
| Jan 25 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 304,397 | 0 | 0 | |
| Jan 25 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 82.49 | 23,236 | 1,916,668 | 886,011 | 909.2 K to 886 K (-2.56 %) |
| Jan 25 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 81.90 | 181,250 | 14,844,194 | 909,247 | 1.1 M to 909.2 K (-16.62 %) |
| Jan 25 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 80.78 | 36,453 | 2,944,783 | 1,090,497 | 1.1 M to 1.1 M (-3.23 %) |
| Jan 25 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 79.89 | 28,605 | 2,285,339 | 1,126,950 | 1.2 M to 1.1 M (-2.48 %) |
| Jan 25 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 78.80 | 34,853 | 2,746,416 | 1,155,555 | 1.2 M to 1.2 M (-2.93 %) |
| Jan 25 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 304,397 | 0 | 1,190,408 | 886 K to 1.2 M (+34.36 %) |
| Jan 04 2019 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | A | 0.00 | 304,397 | 0 | 304,397 | |
| Jul 02 2018 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 13.55 | 2,878 | 38,997 | 2,878 | 0 to 2.9 K |
| May 31 2018 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Option Exercise | A | 17.00 | 12,500 | 212,500 | 12,500 | |
| Mar 13 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 24,400 | 0 | 24,400 | |
| Mar 13 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 52.19 | 11,459 | 598,091 | 882,439 | 893.9 K to 882.4 K (-1.28 %) |
| Mar 13 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 24,400 | 0 | 893,898 | 869.5 K to 893.9 K (+2.81 %) |
| Feb 28 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | A | 0.00 | 82,300 | 0 | 82,300 | |
| Feb 28 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | A | 44.37 | 68,300 | 3,030,471 | 68,300 | |
| Feb 28 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 20,025 | 0 | 40,050 | |
| Feb 28 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 44.10 | 9,085 | 400,630 | 869,498 | 878.6 K to 869.5 K (-1.03 %) |
| Feb 28 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 20,025 | 0 | 878,583 | 858.6 K to 878.6 K (+2.33 %) |
| Feb 13 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.83 | 101,488 | 84,235 | 163,514 | |
| Feb 13 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 46.29 | 9,458 | 437,839 | 830,052 | 839.5 K to 830.1 K (-1.13 %) |
| Feb 13 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 46.54 | 50,504 | 2,350,456 | 839,510 | 890 K to 839.5 K (-5.67 %) |
| Feb 13 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 44.60 | 41,526 | 1,851,977 | 890,014 | 931.5 K to 890 K (-4.46 %) |
| Feb 13 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.83 | 101,488 | 84,235 | 931,540 | 830.1 K to 931.5 K (+12.23 %) |
| Jan 25 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.83 | 110,439 | 91,664 | 265,002 | |
| Jan 25 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 51.66 | 30,036 | 1,551,660 | 830,052 | 860.1 K to 830.1 K (-3.49 %) |
| Jan 25 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 50.72 | 41,588 | 2,109,427 | 860,088 | 901.7 K to 860.1 K (-4.61 %) |
| Jan 25 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 49.54 | 26,738 | 1,324,707 | 901,676 | 928.4 K to 901.7 K (-2.88 %) |
| Jan 25 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 48.87 | 12,077 | 590,167 | 928,414 | 940.5 K to 928.4 K (-1.28 %) |
| Jan 25 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.83 | 110,439 | 91,664 | 940,491 | 830.1 K to 940.5 K (+13.31 %) |
| Jan 17 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.83 | 125,402 | 104,084 | 375,441 | |
| Jan 17 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 53.24 | 25,912 | 1,379,659 | 830,052 | 856 K to 830.1 K (-3.03 %) |
| Jan 17 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 52.68 | 99,490 | 5,240,934 | 855,964 | 955.5 K to 856 K (-10.41 %) |
| Jan 17 2018 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.83 | 125,402 | 104,084 | 955,454 | 830.1 K to 955.5 K (+15.11 %) |
| Dec 26 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.83 | 123,512 | 102,515 | 500,843 | |
| Dec 26 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 53.36 | 27,065 | 1,444,053 | 830,052 | 857.1 K to 830.1 K (-3.16 %) |
| Dec 26 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 52.37 | 96,447 | 5,050,736 | 857,117 | 953.6 K to 857.1 K (-10.11 %) |
| Dec 26 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.83 | 123,512 | 102,515 | 953,564 | 830.1 K to 953.6 K (+14.88 %) |
| Dec 08 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.83 | 121,849 | 101,135 | 624,355 | |
| Dec 08 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 53.81 | 28,370 | 1,526,448 | 830,052 | 858.4 K to 830.1 K (-3.30 %) |
| Dec 08 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 53.35 | 93,479 | 4,986,731 | 858,422 | 951.9 K to 858.4 K (-9.82 %) |
| Dec 08 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.83 | 121,849 | 101,135 | 951,901 | 830.1 K to 951.9 K (+14.68 %) |
| Nov 22 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.83 | 134,057 | 111,267 | 746,204 | |
| Nov 22 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 59.50 | 134,057 | 7,976,660 | 830,052 | 964.1 K to 830.1 K (-13.90 %) |
| Nov 22 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.83 | 134,057 | 111,267 | 964,109 | 830.1 K to 964.1 K (+16.15 %) |
| Nov 13 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.83 | 137,815 | 114,386 | 880,261 | |
| Nov 13 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 60.05 | 5,424 | 325,690 | 830,052 | 835.5 K to 830.1 K (-0.65 %) |
| Nov 13 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 59.43 | 80,405 | 4,778,550 | 835,486 | 915.9 K to 835.5 K (-8.78 %) |
| Nov 13 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 58.59 | 51,976 | 3,045,430 | 915,891 | 967.9 K to 915.9 K (-5.37 %) |
| Nov 13 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.83 | 137,815 | 114,386 | 967,867 | 830.1 K to 967.9 K (+16.60 %) |
| Aug 17 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 10.82 | 9,242 | 99,998 | 96,758 | |
| Aug 17 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 10.82 | 9,242 | 99,998 | 830,052 | 820.8 K to 830.1 K (+1.13 %) |
| Jul 28 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | A | 0.00 | 137,300 | 0 | 137,300 | |
| Jul 28 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | A | 21.68 | 240,000 | 5,203,200 | 240,000 | |
| Jul 28 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Grant | A | 5.95 | 3,571 | 21,247 | 820,810 | 817.2 K to 820.8 K (+0.44 %) |
| Mar 14 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 21.16 | 12,059 | 255,168 | 817,239 | 829.3 K to 817.2 K (-1.45 %) |
| Mar 13 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 24,400 | 0 | 48,800 | |
| Mar 13 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 24,400 | 0 | 829,298 | 804.9 K to 829.3 K (+3.03 %) |
| Feb 28 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 20,025 | 0 | 60,075 | |
| Feb 28 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 19,500 | 0 | 19,500 | |
| Feb 28 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 21.48 | 19,557 | 420,084 | 804,898 | 824.5 K to 804.9 K (-2.37 %) |
| Feb 28 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 20,025 | 0 | 824,455 | 804.4 K to 824.5 K (+2.49 %) |
| Feb 28 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 19,500 | 0 | 804,430 | 784.9 K to 804.4 K (+2.48 %) |
| Feb 28 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Sell | S | 21.57 | 7,577 | 163,436 | 784,930 | 792.5 K to 784.9 K (-0.96 %) |
| Feb 24 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.00 | 19,375 | 0 | 0 | |
| Feb 24 2017 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 0.00 | 19,375 | 0 | 792,507 | 773.1 K to 792.5 K (+2.51 %) |
| Feb 07 2017 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Option Exercise | A | 12.05 | 25,000 | 301,250 | 25,000 | |
| Nov 15 2016 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 9.07 | 33,075 | 299,990 | 94,425 | |
| Nov 15 2016 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Option Exercise | M | 0.83 | 600,000 | 498,000 | 1,018,076 | |
| Nov 15 2016 | EXAS | EXACT SCIENCES COR ... | Conroy Kevin T | President and CEO | Buy | M | 9.07 | 33,075 | 299,990 | 773,132 | 740.1 K to 773.1 K (+4.47 %) |